Registered number
06141908
Innate Health Limited
Filleted Accounts
31 March 2022
Innate Health Limited
Registered number: 06141908
Balance Sheet
as at 31 March 2022
Notes 2022 2021
£ £
Fixed assets
Tangible assets 3 220,000 220,000
Current assets
Cash at bank and in hand 2,420 8,974
Creditors: amounts falling due within one year 4 (182,768) (181,484)
Net current liabilities (180,348) (172,510)
Net assets 39,652 47,490
Capital and reserves
Called up share capital 1 1
Revaluation reserve 5 30,000 30,000
Profit and loss account 9,651 17,489
Shareholder's funds 39,652 47,490
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
J Karalus
Director
Approved by the board on 14 August 2022
Innate Health Limited
Notes to the Accounts
for the year ended 31 March 2022
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes.
Investment Property
Investment property, which is property held to earn rentals and/or for capital appreciation, is measured using the fair value model and stated at its fair value as the reporting end date. The surplus or deficit on revaluation is recognised in the profit and loss account.



Where fair value cannot be achieved without undue cost or effort, investment property is accounted for as tangible fixed assets. Gains or losses arising from changes in the fair value of investment property are included in profit and loss for the period in which they arise.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
2 Employees 2022 2021
Number Number
Average number of persons employed by the company 1 1
3 Tangible fixed assets
Land and buildings
£
Cost
At 1 April 2021 220,000
At 31 March 2022 220,000
Depreciation
At 31 March 2022 -
Net book value
At 31 March 2022 220,000
At 31 March 2021 220,000
4 Creditors: amounts falling due within one year 2022 2021
£ £
Other creditors 182,768 181,484
5 Revaluation reserve 2022 2021
£ £
At 1 April 2021 30,000 -
Gain on revaluation of land and buildings - 30,000
At 31 March 2022 30,000 30,000
The investment property was revalued at the year end by the director on an open market basis.
6 Related party transactions
J Karalus is owed £182,768 (2021: £181,484) by the company. The loan is unsecured. Interest of £5,203 (2021: £4,433) and a salary of £nil (2021: £8,500) was charged.
7 Controlling party
The controlling party is J Karalus.
8 Other information
Innate Health Limited is a private company limited by shares and incorporated in England. Its registered office is:
13 Otterton Close
Harpenden
AL5 3BE
Innate Health Limited 06141908 false 2021-04-01 2022-03-31 2022-03-31 VT Final Accounts April 2022 J Karalus No description of principal activity 06141908 2020-04-01 2021-03-31 06141908 core:RevaluationReserve core:LandBuildings 2020-04-01 2021-03-31 06141908 core:WithinOneYear 2021-03-31 06141908 core:ShareCapital 2021-03-31 06141908 core:OtherReservesSubtotal 2021-03-31 06141908 core:RetainedEarningsAccumulatedLosses 2021-03-31 06141908 core:RevaluationReserve 2020-03-31 06141908 2021-04-01 2022-03-31 06141908 bus:PrivateLimitedCompanyLtd 2021-04-01 2022-03-31 06141908 bus:AuditExempt-NoAccountantsReport 2021-04-01 2022-03-31 06141908 bus:Director40 2021-04-01 2022-03-31 06141908 1 2021-04-01 2022-03-31 06141908 2 2021-04-01 2022-03-31 06141908 core:RevaluationReserve core:LandBuildings 2021-04-01 2022-03-31 06141908 countries:England 2021-04-01 2022-03-31 06141908 bus:FRS102 2021-04-01 2022-03-31 06141908 bus:FullAccounts 2021-04-01 2022-03-31 06141908 2022-03-31 06141908 core:WithinOneYear 2022-03-31 06141908 core:ShareCapital 2022-03-31 06141908 core:OtherReservesSubtotal 2022-03-31 06141908 core:RetainedEarningsAccumulatedLosses 2022-03-31 06141908 core:LandBuildings 2022-03-31 06141908 core:RevaluationReserve 2022-03-31 06141908 2021-03-31 06141908 core:LandBuildings 2021-03-31 06141908 core:RevaluationReserve 2021-03-31 iso4217:GBP xbrli:pure